2022 annual financial data
Harvard Bioscience 2022 Operating margin
Harvard Bioscience 2022 operating margin with verified reported values.
Direct answer
Operating margin was -6.12%.
Operating income was -6,933,000 USD and net income was -9,516,000 USD.
Operating cash flow was 1,152,000 USD.
Get free Harvard Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 113,335,000 USD
- Operating income
- -6,933,000 USD
- Net income
- -9,516,000 USD
- Operating cash flow
- 1,152,000 USD